Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): AR107829A1
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 02-11-2018
Patent type: Polymorphs

Click within the document, or manually enter the page number below

CILFA opposition, LSD1 inhibitor, (AR107871A1)

Countries: Argentina Date: 2018
CILFA opposition, osimertinib, (AR115019A2)

Countries: Argentina Date: 2021
CILFA opposition, cannabinoid, (AR113749A1)

Countries: Argentina Date: 2020
CILFA opposition, PI3K delta INHIBITORS, (AR100619A1)

Countries: Argentina Date: 2017
CILFA opposition, Desmopressin, (AR107948A2)

Countries: Argentina Date: 2018
CILFA opposition, eltrombopag, (AR107711A2)

Countries: Argentina Date: 2018
CILFA opposition, progesterone, (AR108074A1)

Countries: Argentina Date: 2018
CILFA opposition, Firsocostat - 2-(R)-2-(I-(2-(2-methoxyphenyl)-2- tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol2-yl)-2,4-dioxo-1,2-dihydrothieno[2, 3-d]pyrlmidin-3 (4H)- yl)-2-methylpropanoic acid, (AR107790A1)

Countries: Argentina Date: 2018
CILFA opposition, progesterone - estradiol, (AR108073A1)

Countries: Argentina Date: 2018
CILFA opposition, mesalazine, (AR108231A1)

Countries: Argentina Date: 2018

Cilfa Opposition, Vinorelbine, (Ar107829 A1)